Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Galapagos Receives FDA RMAT Designation For GLPG5101 As Anti-CD19/4-1BB CAR-T Therapy Targeting Relapsed/Refractory Mantle Cell Lymphoma

Author: Benzinga Newsdesk | August 06, 2025 01:39am

Posted In: GLPG